AtriCure, Inc. (ATRC)
55.98
-1.55
(-2.69%)
USD |
NASDAQ |
Nov 12, 16:00
55.98
0.00 (0.00%)
Pre-Market: 20:00
AtriCure Price to Book Value : 5.345 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 5.345 |
| November 11, 2026 | 5.493 |
| November 10, 2026 | 5.372 |
| November 09, 2026 | 5.517 |
| November 06, 2026 | 5.590 |
| November 05, 2026 | 5.851 |
| November 04, 2026 | 6.257 |
| November 03, 2026 | 5.768 |
| November 02, 2026 | 5.717 |
| October 30, 2026 | 5.848 |
| October 29, 2026 | 5.966 |
| October 28, 2026 | 5.864 |
| October 27, 2026 | 5.873 |
| October 26, 2026 | 5.832 |
| October 23, 2026 | 5.630 |
| October 22, 2026 | 5.662 |
| October 21, 2026 | 5.506 |
| October 20, 2026 | 5.506 |
| October 19, 2026 | 5.302 |
| October 16, 2026 | 5.354 |
| October 15, 2026 | 5.517 |
| October 14, 2026 | 5.471 |
| October 13, 2026 | 5.43 |
| October 12, 2026 | 5.469 |
| October 09, 2026 | 5.329 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.045 |
| October 07, 2026 | 5.090 |
| October 06, 2026 | 5.125 |
| October 05, 2026 | 5.382 |
| October 02, 2026 | 5.265 |
| October 01, 2026 | 5.117 |
| September 30, 2026 | 5.366 |
| September 29, 2026 | 5.717 |
| September 28, 2026 | 5.753 |
| September 25, 2026 | 5.750 |
| September 24, 2026 | 5.985 |
| September 23, 2026 | 5.905 |
| September 22, 2026 | 5.794 |
| September 21, 2026 | 5.744 |
| September 18, 2026 | 5.722 |
| September 17, 2026 | 5.823 |
| September 16, 2026 | 5.628 |
| September 15, 2026 | 5.537 |
| September 14, 2026 | 5.495 |
| September 11, 2026 | 5.372 |
| September 10, 2026 | 5.216 |
| September 09, 2026 | 5.223 |
| September 08, 2026 | 5.292 |
| September 04, 2026 | 5.074 |
| September 03, 2026 | 5.167 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Abbott Laboratories | 3.640 |
| Boston Scientific Corp. | 2.500 |
| AngioDynamics, Inc. | 3.101 |
| Alphatec Holdings, Inc. | -- |
| Baxter International, Inc. | 2.048 |
Price to Book Value Related Metrics
| PE Ratio | 184.39 |
| PS Ratio | 4.644 |
| Price to Free Cash Flow | 51.74 |
| Price | 55.98 |
| Earnings Yield | 0.54% |
| Market Cap | 2.850B |
| Operating PE Ratio | 151.86 |
| Normalized PE Ratio | 175.93 |